Trends in Cardiovascular Medicine最新文献_第6页

Happy heart syndrome – The impact of different triggers on the characteristics of takotsubo syndrome 快乐心综合征：不同触发因素对Takotsubo综合征特征的影响。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-04-01 DOI: 10.1016/j.tcm.2024.12.002

Thomas Stiermaier, Ingo Eitel

引用次数: 0

Technological interventions to address cardiovascular health disparities impacting racial minorities: Opportunities and challenges 解决影响少数种族心血管健康差异的技术干预：机遇与挑战。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-30 DOI: 10.1016/j.tcm.2025.03.005

Audrey Todd , Carl J Lavie , Shady Abohashem

引用次数: 0

Impact of medical versus surgical weight loss on cardiovascular outcomes 内科与外科减肥对心血管结果的影响

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-28 DOI: 10.1016/j.tcm.2025.03.004

Alexander Ostapenko , Bestoun Ahmed

{"title":"Impact of medical versus surgical weight loss on cardiovascular outcomes","authors":"Alexander Ostapenko , Bestoun Ahmed","doi":"10.1016/j.tcm.2025.03.004","DOIUrl":"10.1016/j.tcm.2025.03.004","url":null,"abstract":"<div><div>Obesity contributes to cardiovascular disease in two ways - directly, as an independent risk factor, and indirectly, through its contribution to comorbidities such as hypertension, diabetes, dyslipidemia. This cascade of multiplicative effects means that early management of obesity is instrumental in risk reduction and prevention of adverse cardiovascular outcomes. The amount and sustainability of weight loss has been extensively studied and stratified by medical versus surgical weight loss. Medical weight loss has historically been inferior by both parameters; however, new therapies targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptors have demonstrated very promising results independently for both weight loss and cardiovascular disease. In this review, we compare cardiovascular outcomes between bariatric surgical approaches and novel GLP-1/GIP medications. We aim to answer the following question: In this era of new pharmacological weight loss options, does the method of weight loss—surgical or medical—impact cardiovascular risk mitigation, or is the key factor the maintenance of a healthier weight, regardless of the method?</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"35 6","pages":"Pages 374-381"},"PeriodicalIF":7.3,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Advances in the screening, diagnosis, and treatment of transthyretin amyloid cardiomyopathy: New insights and future directions 转甲状腺素淀粉样变性心肌病的筛查、诊断和治疗进展：新见解和未来方向。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-25 DOI: 10.1016/j.tcm.2025.03.002

Andrew A. Girard , Talal Asif , Brett W. Sperry

{"title":"Advances in the screening, diagnosis, and treatment of transthyretin amyloid cardiomyopathy: New insights and future directions","authors":"Andrew A. Girard , Talal Asif , Brett W. Sperry","doi":"10.1016/j.tcm.2025.03.002","DOIUrl":"10.1016/j.tcm.2025.03.002","url":null,"abstract":"<div><div>Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive form of heart failure caused by myocardial tissue infiltration with fibrillar amyloid deposits. ATTR-CM has been traditionally underrecognized and regarded by clinicians as a challenging condition to manage, owing to limited availability of effective screening methods, diagnostic testing, and therapeutic options. More recently, multiple clinical trials have emerged evaluating the efficacy of novel pharmacologic therapies which target amyloid generation and pre-existing amyloid deposits. Results reveal robust treatment benefits in function and survival, offering clinicians and patients new therapeutics which alter the clinical trajectory of ATTR-CM. Importantly, the benefits of treatment with these therapies appear to be more pronounced when initiated at an early stage of disease. As a result, a renewed interest in the early detection of ATTR-CM has developed, with efforts currently underway to promote increased disease awareness and enhance diagnosis through standardized screening algorithms and advanced imaging techniques. This review will provide an in-depth description of the advancements in ATTR-CM screening, diagnosis, and treatment that are currently available for implementation in routine care. Furthermore, we highlight several investigational modalities on the horizon for ATTR-CM with a particular focus on their potential roles in future clinical practice.</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"35 6","pages":"Pages 354-362"},"PeriodicalIF":7.3,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Contemporary use of non transvenous ICD 非经静脉ICD的当代应用。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-17 DOI: 10.1016/j.tcm.2025.03.003

Ayesha Shaik, Theofanie Mela

引用次数: 0

Management of angina pectoris 心绞痛的处理。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-12 DOI: 10.1016/j.tcm.2025.03.001

Riccardo Rinaldi , Vijay Kunadian , Filippo Crea , Rocco A. Montone

{"title":"Management of angina pectoris","authors":"Riccardo Rinaldi , Vijay Kunadian , Filippo Crea , Rocco A. Montone","doi":"10.1016/j.tcm.2025.03.001","DOIUrl":"10.1016/j.tcm.2025.03.001","url":null,"abstract":"<div><div>Angina pectoris, a primary manifestation of ischemic heart disease, imposes a significant clinical and economic burden globally. This review highlights recent advancements in the management of angina, emphasizing a patient-centred approach that integrates pharmacological, interventional, and lifestyle strategies to reduce cardiovascular risk and improve patient outcomes. For obstructive coronary artery disease, optimal medical therapy represents the cornerstone of treatment. Individualized regimens should be tailored to clinical factors such as blood pressure, heart rate, left ventricular function, comorbidities like heart failure and diabetes, concomitant medications, patient preferences, and drug availability. Myocardial revascularization is reserved for select cases to alleviate symptoms or improve prognosis. For angina or ischemia with non-obstructive coronary arteries (ANOCA/INOCA), precise endotype classification, differentiating microvascular angina, vasospastic angina, mixed type and non-coronary chest pain, enables personalized treatment strategies. Lifestyle interventions, including smoking cessation, weight management, adherence to Mediterranean diet, and exercise therapy, are essential components of care, promoting improved cardiovascular outcomes and quality of life. Structured exercise programs, particularly within cardiac rehabilitation settings, have demonstrated efficacy in enhancing functional capacity and reducing adverse events. Emerging therapies, including pharmacological agents and novel interventional approaches such as the coronary sinus reducer, hold promise for addressing unmet needs in refractory angina and challenging ANOCA/INOCA cases. Future directions should prioritize the integration of precision medicine, digital health technologies, and multidisciplinary care to optimize outcomes and advance personalized angina management.</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"35 6","pages":"Pages 341-350"},"PeriodicalIF":7.3,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143631051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Editorial commentary: Atrial fibrillation in patients with cardiomyopathy – Protecting the vulnerable 心肌病患者心房颤动——保护弱势群体。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-11 DOI: 10.1016/j.tcm.2025.02.011

James W. Salazar, Daniel P. Morin

引用次数: 0

Editorial commentary: Advancing our understanding of cardiac tumors 推进我们对心脏肿瘤的认识。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-07 DOI: 10.1016/j.tcm.2025.02.010

Massimo Imazio

引用次数: 0

Editorial commentary: TEER in MR: Innovations, challenges and the road to long-term validation MR中的TEER：创新、挑战和长期验证之路。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-05 DOI: 10.1016/j.tcm.2025.02.009

Tulio Caldonazo, Hristo Kirov

引用次数: 0

Editorial commentary: Is it the atrial arrhythmia or the atrial myopathy? Yes! (It's both) 是心房心律失常还是心房肌病？两者都有。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-03-04 DOI: 10.1016/j.tcm.2025.02.007

James P. Daubert

引用次数: 0